Company Profile

Scanogen Inc (AKA: Twistnostics LLC)
Profile last edited on: 11/17/2023      CAGE: 6NSE7      UEI: JK9PMLM41J77

Business Identifier: Single Molecule Scanning proprietary genetic diagnostic
Year Founded
First Award
Latest Award
Program Status
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

3102 Lord Baltimore Drive Suite 214
Baltimore, MD 21244
   (443) 640-5097
Location: Single
Congr. District: 07
County: Baltimore

Public Profile

Scanogen is a biotechnology and medical device start-up developing Single Molecule Scanning, a proprietary technology for rapid and ultra-sensitive detection of biomolecules. Scanogen is using this technology to develop point of care tests that will improve health care by providing easy and inexpensive access to the genetic information present in patient samples. The company is focused on three areas: point-of-care detection of infectious diseases, drug resistance detection and early cancer detection. The firm's core technology, Single Molecule Scanning, uses biosensors that consist of DNA molecules and micron-sized particles to convert nucleic acid hybridization into a mechanical signal which can be detected using standard semiconductor technology. In addition, the bound target is subjected to a disrupting force which allows for rapid detection with extremely low background noise.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
Revenue Range
VC funded?
Privately Held
Stock Info
IP Holdings

Awards Distribution by Agency

Most Recent SBIR Projects

Key People / Management

  Alfredo A Celedon -- Founder and CEO

  Carlos Torres Bedós -- Material Scientist

  Justin Galloway